Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

INTRODUCTION: Insulin degludec is a new, ultra-long-acting basal insulin. The aim of this study was to analyze the changes of basal insulin dose and blood glucose profile in basal–bolus therapy of type 1 diabetes mellitus (T1DM) at the switching of basal insulin from insulin glargine or detemir to i...

詳細記述

保存先:
書誌詳細
主要な著者: Kusunoki, Yoshiki, Katsuno, Tomoyuki, Miyakoshi, Kana, Ikawa, Takashi, Nakae, Rie, Ochi, Fumihiro, Tokuda, Masaru, Akagami, Takafumi, Murai, Kazuki, Miuchi, Masayuki, Hamaguchi, Tomoya, Miyagawa, Jun-ichiro, Namba, Mitsuyoshi
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2013
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889322/
https://ncbi.nlm.nih.gov/pubmed/24282104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-013-0048-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料